Children younger than 18 months can be protected by malaria vaccine

An African experiment related to malaria vaccine proves that this shot can protect children up to 18 months. Sub-Saharan Africa is affected by 660,000 deaths yearly from which the majority is children. GlaxoSmithKline (GSK) states that the results of this trial prove 27% reduction of malaria cases in children aged between 6 and 12 weeks. According to GSK, the vaccine proves “an acceptable and tolerability profile”. “Many millions of malaria cases fill the wards of our hospitals. Progress is being made with bed nets and other measures, but we need more tools to battle this terrible disease”, said Dr. Halidou Tinto, Principal Investigator from the Nanoro, Burkina Faso. Dr. Tinto believes that families would be able to save money and time by paying attention to these children and could focus more on work and other activities, but children would also have the possibility to encounter the benefits of a healthier life.